Patents by Inventor Geetha Srikrishna

Geetha Srikrishna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100249383
    Abstract: The present invention provides methods and compositions involved in the inflammatory response, as well as various pathological processes. In particular, the present invention provides novel antibodies directed against novel glycans that are enriched on endothelial cell surfaces. In addition, the present invention provides methods and compositions involved in a previously unrecognized pathway of the inflammatory response and various pathological processes. In addition the present invention provides methods and compositions suitable to mediate the inflammatory response in various settings, as well as methods and compositions for the identification of other inflammatory response mediators.
    Type: Application
    Filed: July 13, 2009
    Publication date: September 30, 2010
    Inventors: Hudson Freeze, Geetha Srikrishna, Ajit Varki, Nissi Varki
  • Publication number: 20100021472
    Abstract: Aspects of the present invention relate to molecular biology and medicine. More specifically, some embodiments include methods for treating and/or diagnosing inflammation and/or cancer using agents that inhibit the binding of a pro-inflammatory protein or protein complex (e.g., S100A8 and/or S100A9) to a carboxylated glycan expressed on a myeloid (e.g., MDSC), monocytic, dendritic, endothelial, or tumor cell.
    Type: Application
    Filed: July 27, 2009
    Publication date: January 28, 2010
    Inventors: Geetha Srikrishna, Hudson H. Freeze, Suzanne Ostrand-Rosenberg, Pratima Sinha
  • Publication number: 20050118688
    Abstract: The present invention provides methods and compositions involved in the inflammatory response, as well as various pathological processes. In particular, the present invention provides novel antibodies directed against novel glycans that are enriched on endothelial cell surfaces. In addition, the present invention provides methods and compositions involved in a previously unrecognized pathway of the inflammatory response and various pathological processes. In addition the present invention provides methods and compositions suitable to mediate the inflammatory response in various settings, as well as methods and compositions for the identification of other inflammatory response mediators.
    Type: Application
    Filed: December 27, 2002
    Publication date: June 2, 2005
    Inventors: Hudson Freeze, Geetha Srikrishna, Ajit Varki